BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29392699)

  • 41. Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization.
    Hinrichs CN; Ingargiola M; Käubler T; Löck S; Temme A; Köhn-Luque A; Deutsch A; Vovk O; Stasyk O; Kunz-Schughart LA
    Mol Cancer Ther; 2018 Feb; 17(2):393-406. PubMed ID: 28830984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
    Wang L; Long L; Wang W; Liang Z
    J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain.
    Ghoochani A; Yakubov E; Sehm T; Fan Z; Hock S; Buchfelder M; Eyüpoglu IY; Savaskan NE
    Oncotarget; 2016 Jan; 7(2):1838-53. PubMed ID: 26673818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific.
    Castro ML; McConnell MJ; Herst PM
    Free Radic Biol Med; 2014 Sep; 74():200-9. PubMed ID: 24992837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
    Sun LQ; Li YX; Guillou L; Coucke PA
    Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
    Hausmann C; Temme A; Cordes N; Eke I
    Oncotarget; 2015 Oct; 6(33):34592-605. PubMed ID: 26460618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.
    Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A
    Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
    Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ionizing radiation-induced gene expression changes in TP53 proficient and deficient glioblastoma cell lines.
    Godoy PR; Mello SS; Magalhães DA; Donaires FS; Nicolucci P; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Mutat Res; 2013 Aug; 756(1-2):46-55. PubMed ID: 23817105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PERK Regulates Glioblastoma Sensitivity to ER Stress Although Promoting Radiation Resistance.
    Dadey DYA; Kapoor V; Khudanyan A; Thotala D; Hallahan DE
    Mol Cancer Res; 2018 Oct; 16(10):1447-1453. PubMed ID: 29991528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.
    Stegen B; Butz L; Klumpp L; Zips D; Dittmann K; Ruth P; Huber SM
    Mol Cancer Res; 2015 Sep; 13(9):1283-95. PubMed ID: 26041939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
    Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL
    BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy.
    Yao KC; Komata T; Kondo Y; Kanzawa T; Kondo S; Germano IM
    J Neurosurg; 2003 Feb; 98(2):378-84. PubMed ID: 12593626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone.
    Goffart N; Lombard A; Lallemand F; Kroonen J; Nassen J; Di Valentin E; Berendsen S; Dedobbeleer M; Willems E; Robe P; Bours V; Martin D; Martinive P; Maquet P; Rogister B
    Neuro Oncol; 2017 Jan; 19(1):66-77. PubMed ID: 27370398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wortmannin sensitizes human glioblastoma cell lines carrying mutant and wild type TP53 gene to radiation.
    Kubota N; Okada S; Inada T; Ohnishi K; Ohnishi T
    Cancer Lett; 2000 Dec; 161(2):141-7. PubMed ID: 11090962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
    Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
    Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
    Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.